{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:39:33Z","timestamp":1762659573142},"reference-count":22,"publisher":"BMJ","issue":"e2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2017,6,5]]},"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1136\/ejhpharm-2017-001225","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T01:01:09Z","timestamp":1500512469000},"page":"e102-e108","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Investigations into the physical and chemical stability of concentrated co-trimoxazole intravenous infusions"],"prefix":"10.1136","volume":"25","author":[{"given":"Israa","family":"Khaleel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Tabish R","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhur D","family":"Shastri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew Suji","family":"Eapen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long Chiau","family":"Ming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troy","family":"Wanandy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul P","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,7,19]]},"reference":[{"key":"2024052710154658000_25.e2.e102.1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028016650107"},{"key":"2024052710154658000_25.e2.e102.2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000232491.15369.AB"},{"key":"2024052710154658000_25.e2.e102.3","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.212"},{"key":"2024052710154658000_25.e2.e102.4","doi-asserted-by":"publisher","DOI":"10.3201\/eid2009.131668"},{"key":"2024052710154658000_25.e2.e102.5","unstructured":"Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. 2016;Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. 2016. http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf. (accessed 3 Nov 2016)."},{"key":"2024052710154658000_25.e2.e102.6","unstructured":"Hap L . DBL\u2122 Sulfamethoxazole and Trimethoprim Concentrate\u00a0Injection BP Data Sheet. 2015. https:\/\/www.ebs.tga.gov.au\/ebs\/picmi\/picmirepository.nsf\/pdf?OpenAgent&id=CP-2009-PI-00440-3&d=2016103116114622483. (accessed 31 Oct 2016)."},{"key":"2024052710154658000_25.e2.e102.7","doi-asserted-by":"publisher","DOI":"10.1177\/1753465810380102"},{"key":"2024052710154658000_25.e2.e102.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1412877"},{"key":"2024052710154658000_25.e2.e102.9","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/jps.2600841021","article-title":"A physiochemical approach to the investigation of the stability of trimethoprim-sulfamethoxazole (co-trimoxazole) mixtures for injectables","volume":"84","author":"Giordano","year":"1995","journal-title":"J Pharm Sci"},{"key":"2024052710154658000_25.e2.e102.10","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.13.1140.34611"},{"key":"2024052710154658000_25.e2.e102.11","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200212000-00021"},{"key":"2024052710154658000_25.e2.e102.12","first-page":"1004","article-title":"Stability of trimethoprim-sulfamethoxazole injection in two infusion fluids","volume":"38","author":"Lesko","year":"1981","journal-title":"Am J Hosp Pharm"},{"key":"2024052710154658000_25.e2.e102.13","first-page":"1681","article-title":"Stability of trimethoprim-sulfamethoxazole injection in five infusion fluids","volume":"39","author":"Deans","year":"1982","journal-title":"Am J Hosp Pharm"},{"key":"2024052710154658000_25.e2.e102.14","first-page":"732","article-title":"Stability of concentrated trimethoprim-sulfamethoxazole admixtures","volume":"46","author":"Jarosinski","year":"1989","journal-title":"Am J Hosp Pharm"},{"key":"2024052710154658000_25.e2.e102.15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/ijpp.12245","article-title":"Eliminating the use of intravenous glass bottles using a FOCUS-PDCA model and providing a practical stability reference guide","volume":"24","author":"Maraiki","year":"2016","journal-title":"Int J Pharm Pract"},{"key":"2024052710154658000_25.e2.e102.16","unstructured":"Curtis JM , Edwards DJ . Stability of Trimethoprim in Admixtures of Trimethoprim\u2013Sulfamethoxazole Prepared in Polyvinylchloride Bags and Glass Bottles. Can J Hosp Pharm 2002;55."},{"key":"2024052710154658000_25.e2.e102.17","unstructured":"Wills S . Injection of drugs. Drugs of abuse. 2nd ed. London: Pharmaceutical Press, 2005."},{"key":"2024052710154658000_25.e2.e102.18","unstructured":"Liu J , Goyer RA , Waalkes MP , et al . Doull\u2019s Toxicology: The basic science of poisons. New York: McGraw Hill-Companies, Inc, 2008."},{"key":"2024052710154658000_25.e2.e102.19","unstructured":"U.S\u00a0Pharmacopoeia-National Formularyformulary (USP 39 NF 34). General Requirements Injection. Rockville: Md: United States Pharmacopeial Convention, 2016."},{"key":"2024052710154658000_25.e2.e102.20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1365-2710.2002.00406.x","article-title":"Comparison of ceftazidime degradation in glass bottles and plastic bags under various conditions","volume":"27","author":"Ars\u00e8ne","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"2024052710154658000_25.e2.e102.21","first-page":"207","article-title":"Stability of trimethoprim in admixtures of trimethoprim\u2013sulfamethoxazole prepared in polyvinylchloride bags and glass bottles","volume":"55","author":"Curtis","year":"2002","journal-title":"Can J Hosp Pharm"},{"key":"2024052710154658000_25.e2.e102.22","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000000268"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2017-001225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T17:16:00Z","timestamp":1716830160000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2017-001225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,19]]},"references-count":22,"journal-issue":{"issue":"e2","published-online":{"date-parts":[[2018,9,16]]},"published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1136\/ejhpharm-2017-001225"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2017-001225","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,19]]}}}